AdaptHealth Corp Warrant
AHCOW
AHCOW was delisted on the 5th of December, 2019.
0 hedge funds and large institutions have $0 invested in AdaptHealth Corp Warrant in 2020 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $302K → $0 (-$302K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$302K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Marshall Wace
London,
United Kingdom
| – | -$302K | -166,663 | Closed |
|
AHCOW Hedge Fund Activity: Q1 2020 in Review
0 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in AdaptHealth Corp Warrant (AHCOW) for Q1 2020, worth a combined $0 — down 100% from $302K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of AHCOW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Marshall Wace, exiting entirely with an estimated $302K sold.
- 0 institutional investors held AdaptHealth Corp Warrant (AHCOW) as of Q1 2020, down from 1 in Q4 2019.
- Funds reported $0 of AdaptHealth Corp Warrant stock for Q1 2020, down 100% quarter-over-quarter.
- 0 funds opened new AdaptHealth Corp Warrant positions in Q1 2020 and 1 closed out, a net change of -1 holder.
- The largest AdaptHealth Corp Warrant seller in Q1 2020 was Marshall Wace, an estimated $302K sold.
Based on aggregated 13F filings for Q1 2020.